Epilepsiforskningsgruppen ERGO (med forfattere overlege Line Bedos Ulvin, overlege Kjell Heuser og prof. Erik Taubøll) har vært delaktig i en 3-nasjonal studie for å bedre prognostisering av langtidsoverlevelse etter status epilepticus.
Nyslått Oslo-ambassadør og professor Erik Taubøll, Nevrologisk avdeling, Institutt for klinisk medisin (Klinmed) ble hedret for sin innsats med å få European Academy of Neurology - EAN til byen i 2019 under en seremoni på Grand Hotel i Oslo.
Lege og phd stipendiat Toni Berger ved Nevrologisk avdeling, Oslo Universitetssykehus – Rikshospitalet og Institutt for klinisk medisin ved Universitetet i Oslo skal forsvare sin avhandling: "A translational view on epileptogenesis" for graden phd fredag 4 februar.
Arbeidet utgår fra epilepsiforskningsgruppen i Nevrologisk avdeling, ERGO (Epilepsy Research Group of Oslo) og hovedveileder er overlege, phd Kjell Heuser. Prosjektet har vært finansiert fra EU gjennom Horizon2020, Marie Sklodowska Curie programmet.
Disputas blir fredag 4 februar kl 12.15 (digital) https://www.med.uio.no/klinmed/english/research/news-and-events/events/disputations/2022/berger-toni.html
Prøveforelesning fredag 4 februar kl 10.15. Tittel: The role of microglia in neurodegenerative diseases. Therapeutic implications” (digital, Se Digital Trial Lecture)
The Epilepsy Research Group in Department of Neurology (ERGO - Epilepsy Research Group of Oslo) and the Department of Neurosurgery at Ullevål are now starting clinical studies of possible biomarkers for the development of epilepsy after head injuries. In the next round, it may be relevant to try out intervention treatment with medication.
The main study will be part of an international multi-center study we are now participating in and where Oslo could become one of the largest contributors. The project has received support from the CURE Epilepsy Foundation in the USA, which in turn has received USD 10 million from the US Department of Defense to study the mechanisms behind the development of post-traumatic epilepsy.
ERGO - Epilepsy Research Group of Oslo - presented their research at an open public meeting in September during the "Forskningsdagene 2020". Title of the meeting was: "Epilepsy - from basic research to modern clinical treatment".
Senior consultant, MD, PhD Kjell Heuser, discussed the role of glial cells in epilepsy. Thereafter, the PhD candidates Toni Berger, Cecilie Bugge Bakketun and Monika Mochol talked about epigentics in epilepsy (TB), how to use brain slices in the study of epilepsy (CBB) and the use of zebrafish in epilepsy research (MM) to understand basic mechanisms of epileptogenesis.
Scientitsts from the Epilepsy Research Group at the Nevrological Department, ERGO (Epilepsy Research Group of Oslo) have recently, in collaboration with the Letten Center at the University of Oslo, studied how the glia cells contribute actively and are crucial in epilepsy. They have demonstrate that the glial cells are activated prior to the neurons by seizures, which is completely new knowledge. The findings have been achieved through the combination of several completely new techniques that include high-resolution microscopy, the use of biosensors and advanced neurophysiology, and have recently been published in the journal "Cerebral Cortex".
The groundbreaking research on the role of glial cells in epilepsy has been thorougly presented in a popular science form in a feature article (in Norwegian) entitled "The forgotten cells of the brain - a new path into treatment of epilepsy" on the OUS blog "Ekspertsykehuset".
Blog post from the Oslo University Hospial "Expert Hospital" section (in Norwegian):
Hjernens glemte celler – en ny vei i epilepsibehandlingen? (November 2018)